Skip to main content

Table 1 Characteristics of children started on antiretroviral treatment ( n= 26)

From: Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China

Characteristics Numbers(interval) Percentage
Age at start ART (years, median)a 7.7 (1.5–12)  
<2 years 2 7.7%
2–4.9 years 4 15.3%
5–14 years 20 77%
Sex (male/female) 16/10 61.5%/38.5%
Reason for ART   
WHO stage III-IV 6 36.5%
Baseline CD4 count <15% 20 63.5%
Naïve ART regimen   
D4T/3TC/NVP (EFV) 8 30.8%
AZT/3TC/NVP 18 69.2%
Time on ART (months, median)a,b 41 (18–72.3)  
<2 yearsb 5 19.2%
2 years to <3 yearsb 7 26.9%
3 years to <4 yearsb 6 23.1%
>4 yearsb 8 30.8%
HIV transmission   
Blood product or transfusion recipient 9 34.6%
Mother-to-child transmission 17 65.4%
  1. aValues are expressed as median (interquartile range).
  2. bAs of 30 December 2008 (closing date of dataset).
  3. WHO, World Health Organization; ART, antiretroviral therapy; D4T, stavudine; 3TC, lamivudine; AZT, zidovudine;NVP, nevirapine; EFV, efavirenz.